The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020
Open accessAbstract
The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous CBTRUS reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. The average annual age-adjusted incidence rate (AAAIR) of all malignant and non-malignant brain and other CNS tumors was 24.83 per 100,000 population (malignant AAAIR=6.94 and non-malignant AAAIR=17.88). This overall rate was higher in females compared to males (27.85 versus 21.62 per 100,000) and non-Hispanic persons compared to Hispanic persons (25.24 versus 22.61 per 100,000). Gliomas accounted for 26.3% of all tumors. The most commonly occurring malignant brain and other CNS histopathology was glioblastoma (14.2% of all tumors and 50.9% of all malignant tumors), and the most common predominantly non-malignant histopathology was meningioma (40.8% of all tumors and 56.2% of all non-malignant tumors). Glioblastomas were more common in males, and meningiomas were more common in females. In children and adolescents (ages 0-19 years), the incidence rate of all primary brain and other CNS tumors was 6.13 per 100,000 population. There were 86,030 deaths attributed to malignant brain and other CNS tumors between 2016 and 2020. This represents an average annual mortality rate of 4.42 per 100,000 population and an average of 17,206 deaths per year. The five-year relative survival rate following diagnosis of a malignant brain and other CNS tumor was 35.7%, for a non-malignant brain and other CNS tumor the five-year relative survival rate was 91.8%.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Anaplastic oligodendrogliomas (AOs) are central nervous system (CNS) World Health Organization (WHO) grade 3 gliomas characterized by isocitrate dehydrogenase (IDH) mutation (m)IDH and 1p/19q codeletion.”
From BPC 157 Therapy of Myotendinous Junction Injury in Rats (2025) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21763 · Cited by 16,303
The 2021 WHO classification of tumors of the central nervous system: a summary
Louis, D. N., Perry, A., Wesseling, P., Brat, D. J., Cree, I. A., Figarella-Branger, D., Hawkins, C., Ng, H. K., Pfister, S. M., Reifenberger, G., et al. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab106 · Cited by 12,273
Ostrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Self-citationPermutation tests for joinpoint regression with applications to cancer rates
Kim, H.-J., Fay, M. P., Feuer, E. J., & Midthune, D. N. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z · Cited by 6,318
Simple Features for R: Standardized Support for Spatial Vector Data
Pebesma, E. (2018) · The R Journal · doi:10.32614/rj-2018-009 · Cited by 4,701
Erratum to: The 2007 WHO classification of tumours of the central nervous system
Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Scheithauer, B. W., & Kleihues, P. (2007) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-156115 · Cited by 4,442
The epidemiology of glioma in adults: a "state of the science" review
Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou087 · Cited by 2,220
Self-citationOstrom, Q. T., Gittleman, H., Liao, P., Rouse, C., Chen, Y., Dowling, J., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou223 · Cited by 1,718
Self-citationInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
The New WHO Classification of Brain Tumours
Kleihues, P., Burger, P. C., & Scheithauer, B. W. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00752.x · Cited by 1,587
Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac202 · Cited by 1,565
Self-citationInternational Classification of Childhood Cancer, third edition
Steliarova‐Foucher, E., Stiller, C., Lacour, B., & Kaatsch, P. (2005) · Cancer · doi:10.1002/cncr.20910 · Cited by 1,552
Epidemiology and etiology of meningioma
Wiemels, J., Wrensch, M., & Claus, E. B. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0386-3 · Cited by 1,226
Edwards, B. K., Noone, A., Mariotto, A. B., Simard, E. P., Boscoe, F. P., Henley, S. J., Jemal, A., Cho, H., Anderson, R. N., Kohler, B. A., et al. (2014) · Cancer · doi:10.1002/cncr.28509 · Cited by 1,210
Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014
Ostrom, Q. T., Cote, D. J., Ascha, M., Kruchko, C., & Barnholtz-Sloan, J. S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1789 · Cited by 614
Self-citationAge standardization of death rates: implementation of the year 2000 standard.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 612
van den Bent, M. J. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0725-7 · Cited by 577
Efficient interval estimation for age-adjusted cancer rates
Tiwari, R. C., Clegg, L. X., & Zou, Z. (2006) · Statistical Methods in Medical Research · doi:10.1177/0962280206070621 · Cited by 566
Seo, Y., Baba, H., Fukuda, T., Takashima, M., & Sugimachi, K. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2210::aid-cncr3>3.0.co;2-i · Cited by 406
Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review
Johnson, K. J., Cullen, J., Barnholtz-Sloan, J. S., Ostrom, Q. T., Langer, C. E., Turner, M. C., McKean-Cowdin, R., Fisher, J. L., Lupo, P. J., Partap, S., et al. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0207 · Cited by 393
Self-citationOstrom, Q. T., Price, M., Ryan, K., Edelson, J., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac161 · Cited by 321
Self-citationRisk factors for childhood and adult primary brain tumors
Ostrom, Q. T., Fahmideh, M. A., Cote, D. J., Muskens, I. S., Schraw, J. M., Scheurer, M. E., & Bondy, M. L. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz123 · Cited by 314
Self-citationIonizing radiation and the risk of brain and central nervous system tumors: a systematic review
Braganza, M. Z., Kitahara, C. M., Berrington de Gonzalez, A., Inskip, P. D., Johnson, K. J., & Rajaraman, P. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos208 · Cited by 303
Impact of Reporting Delay and Reporting Error on Cancer Incidence Rates and Trends
Clegg, L. X. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.20.1537 · Cited by 278
Wrensch, M., Lee, M., Miike, R., Newman, B., Bargar, G., Davis, R., Wiencke, J., & Neuhaus, J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009154 · Cited by 218
Females have the survival advantage in glioblastoma
Ostrom, Q. T., Rubin, J. B., Lathia, J. D., Berens, M. E., & Barnholtz-Sloan, J. S. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy002 · Cited by 192
Self-citationCancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System
Zullig, L. L., Jackson, G. L., Dorn, R. A., Provenzale, D. T., McNeil, R., Thomas, C. M., & Kelley, M. J. (2012) · Military Medicine · doi:10.7205/milmed-d-11-00434 · Cited by 183
Aldape, K., Simmons, M. L., Davis, R. L., Miike, R., Wiencke, J., Barger, G., Lee, M., Chen, P., & Wrensch, M. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000515)88:10<2342::aid-cncr19>3.0.co;2-x · Cited by 164
Amirian, E. S., Zhou, R., Wrensch, M., Olson, S. H., Scheurer, M. E., Il’yasova, D., Lachance, D. H., Armstrong, G., Mccoy, L. S., Lau, C. C., et al. (2016) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0847 · Cited by 150
Self-citationFamilial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study
Malmer, B., Gr�nberg, H., Bergenheim, A. T., Lenner, P., & Henriksson, R. (1999) · International Journal of Cancer · Cited by 104
Malmer, B., Henriksson, R., & Grönberg, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11213 · Cited by 98
Family and personal medical history and risk of meningioma
Claus, E. B., Calvocoressi, L., Bondy, M. L., Schildkraut, J. M., Wiemels, J. L., & Wrensch, M. (2011) · Journal of neurosurgery · doi:10.3171/2011.6.jns11129 · Cited by 85
Weir, H. K., Johnson, C. J., Mariotto, A. B., Turner, D., Wilson, R. J., Nishri, D., & Ward, K. C. (2014) · JNCI Monographs · doi:10.1093/jncimonographs/lgu018 · Cited by 82
Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma
Gittleman, H. R., Ostrom, Q. T., Stetson, L. C., Waite, K. A., Hodges, T. R., Wright, C. H., Wright, J. M., III, Rubin, J. B., Berens, M. E., Lathia, J. D., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz019 · Cited by 75
Self-citationIorgulescu, J. B., Sun, C., Neff, C., Cioffi, G., Gutierrez, C., Kruchko, C. A., Ruhl, J., Waite, K. A., Negoita, S., Hofferkamp, J., et al. (2022) · Neuro-Oncology · doi:10.1093/neuonc/noac113 · Cited by 75
Self-citationKruchko, C., Ostrom, Q. T., Gittleman, H. R., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy006 · Cited by 68
Self-citationModeling Reporting Delays and Reporting Corrections in Cancer Registry Data
Midthune, D. N., Fay, M. P., Clegg, L. X., & Feuer, E. J. (2005) · Journal of the American Statistical Association · doi:10.1198/016214504000001899 · Cited by 65
Computation of Graphlet Orbits for Nodes and Edges in Sparse Graphs
Hočevar, T., & Demčar, J. (2016) · Journal of Statistical Software · doi:10.18637/jss.v071.i10 · Cited by 63
Consensus Conference on Brain Tumor Definition for Registration
McCarthy, B. J., Surawicz, T. S., Bruner, J. M., et al. (2002) · Neuro-Oncology · doi:10.1093/neuonc/4.2.134 · Cited by 62
Predicting US‐ and state‐level cancer counts for the current calendar year
Zhu, L., Pickle, L. W., Ghosh, K., Naishadham, D., Portier, K. M., Chen, H., Kim, H., Zou, Z., Cucinelli, J. E., Kohler, B., et al. (2012) · Cancer · doi:10.1002/cncr.27405 · Cited by 58
Aggregation of Cancer in First-Degree Relatives of Patients with Glioma
Scheurer, M. E., Etzel, C. J., Liu, M., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0576 · Cited by 50
Report of the Second Workshop on Age Adjustment.
Anderson, R. N., & Rosenberg, H. M. (1998) · PubMed · Cited by 41
Consensus Conference on Brain Tumor Definition for Registration
McCarthy, B. J. (2002) · Neuro-Oncology · doi:10.1215/15228517-4-2-134 · Cited by 39
Ostrom, Q. T., Gittleman, H. R., Kruchko, C., Louis, D. N., Brat, D. J., Gilbert, M. R., Petkov, V. I., & Barnholtz‐Sloan, J. S. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2217-7 · Cited by 37
Self-citationForjaz, G., Barnholtz‐Sloan, J. S., Kruchko, C., et al. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa175 · Cited by 36
Self-citationCancer in first-degree relatives and risk of glioma in adults.
Hill, D. A., Inskip, P. D., Shapiro, W. R., et al. (2003) · PubMed · Cited by 35
Lym, R. L., Ostrom, Q. T., Kruchko, C., et al. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1775-4 · Cited by 26
Self-citationPilocytic astrocytoma: Where do they belong in cancer reporting?
Ostrom, Q. T., Kruchko, C., & Barnholtz‐Sloan, J. S. (2019) · Neuro-Oncology · doi:10.1093/neuonc/noz202 · Cited by 23
Self-citationNeff, C., Price, M., Cioffi, G., et al. (2023) · Cancer · doi:10.1002/cncr.34837 · Cited by 23
Self-citationAre Benign and Borderline Brain Tumors Underreported?
Li, X., Kruchko, C., Wu, X., Hsieh, M., Andrews, P. A., Huang, B., Qiao, B., & Wohler, B. (2016) · PubMed · Cited by 22
Self-citationKruchko, C., Gittleman, H. R., Ruhl, J., et al. (2019) · Neuro-Oncology Practice · doi:10.1093/nop/npz029 · Cited by 21
Self-citationWilson, R. J., O’Neil, M. E., Ntekop, E., et al. (2014) · PubMed · Cited by 20
Waite, K. A., Cioffi, G., Kruchko, C., et al. (2022) · Neuro-Oncology Practice · doi:10.1093/nop/npac025 · Cited by 16
Self-citationOstrom, Q. T., Kruchko, C., Neff, C., et al. (2022) · PubMed · Cited by 4
Self-citation
Research works printed but not linked: 14
- Louis, 2016, WHO Classification of Tumours of the Central Nervous System
- Centers for Disease Control and Prevention National Center for Health Statistics, 2023, National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: U.S. Cancer Statistics Incidence Analytic Database – 2001-2020
- Surveillance Epidemiology and End Results (SEER) Program, SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969-2020) <Katrina/Rita Population Adjustment>
- 2017, International Incidence of Childhood Cancer, Volume III.
- Swerdlow, 2007, WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition
- Kleihues, 2000, Tumours of the nervous system: World Health Organization classification of tumours.
- Ferlay, 2019, Histological groups
- Central Brain Tumor Registry of the United States SEER*Stat Database, 2023, CDC National Program of Cancer Registries and NCI Surveillance, Epidemiology and End Results Incidence Data, 2022 submission (2000–2020)
- 2023, Joinpoint Regression Program, Version 5.0.2.0; Statistical Methodology and Applications Branch, Surveillance Research Program
- Neff, 2022, prevEst (version 2.0)
- Surveillance Epidemiology and End Results (SEER) Program, 2022, SEER*Stat Database: Incidence - SEER Research Plus Data, 8 Registries, Nov 2021 Sub (1975-2019) - Linked To County Attributes - Total U.S., 1969-2020 Counties
- Central Brain Tumor Registry of the United States SEER*Stat Database, 2022, CDC National Program of Cancer Registries and NCI Surveillance, Epidemiology and End Results Incidence Data, 2021 submission (2000–2019)
- Bray, 2017, Data Comparability and Quality
- Johnson, 2007, The 2007 Multiple Primary and Histology Coding Rules.
Cited by
Weller, M., Wen, P. Y., Chang, S. M., Dirven, L., Lim, M., Monje, M., & Reifenberger, G. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00516-y · Cited by 592
Price, M., Ballard, C., Benedetti, J., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., Barnholtz-Sloan, J. S., & Ostrom, Q. T. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae145 · Cited by 526
Self-citationMechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
Large language models as a diagnostic support tool in neuropathology
Hewitt, K. J., Wiest, I. C., Carrero, Z. I., Bejan, L., Millner, T. O., Brandner, S., & Kather, J. N. (2024) · The Journal of Pathology: Clinical Research · doi:10.1002/2056-4538.70009 · Cited by 27
Liu, T., Lin, Y.-C., Chang, P.-C., Hueng, D.-Y., & Li, Y.-F. (2025) · Discover Oncology · doi:10.1007/s12672-025-02662-5 · Cited by 4
Metadata
- Authors
- Ostrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S.
- Affiliations
- Duke University (US)
- Central Brain Tumor Registry of the United States (US)
- Central Brain Tumor Registry of the United States , Hinsdale, IL , USA
- Corresponding author
- Ostrom, Quinn T
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2023-10-04
- Volume
- 25
- Issue
- Supplement_4
- Pages
- iv1-iv99
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- PMC
- PMC10550277
- OpenAlex
- W4387329303
- Cited by
- 1,294
- References
- 55
- Citations by year
- 2026: 347 · 2025: 440 · 2024: 329 · 2023: 74
- FWCI
- 206.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Neuro-Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Centers for Disease Control and Prevention (75D30119C06056)
- American Brain Tumor Association
- National Cancer Institute
- Topics
- Health Sciences › Medicine › Oncology › Glioma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Health Sciences › Medicine › Clinical Neurology › Meningioma and schwannoma management
- Keywords
- primary brain tumors, central nervous system tumors, incidence, mortality, glioblastoma, meningioma, glioma, pediatric brain tumors, relative survival, sex differences, racial and ethnic disparities, age-standardized rates, cancer registry data
- MeSH terms
- Adolescent, Brain, Brain Neoplasms, Child, Female, Glioblastoma, Humans, Male, Meningeal Neoplasms, Meningioma, Registries, United States, Incidence, Central Nervous System Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.